65706 Federal Register / Vol. 62, No. 240 / Monday, December 15, 1997 / Notices

1Copies of the Complaint and the Decision and

Order are available from the Commission’s Public

Reference Branch, H–130, 600 Pennsylvania

Avenue, N.W., Washington, D.C. 20580.

/1/Copies of the Complaint, the Decision and

Order, and the Commissioners’ statements are

TIME AND DATE: 10 a.m., Thursday,

December 18, 1997.

PLACE: Marriner S. Eccles Federal

Reserve Board Building, C Street

entrance between 20th and 21st Streets

NW., Washington, DC 20551.

STATUS: Open.

MATTERS TO BE CONSIDERED:

Discussion Agenda

1. (a) Proposed amendments to

Regulations G (Securities Credit by

Persons Other than Banks, Brokers, or

Dealers), T (Credit by Brokers and

Dealers),U (Credit by Banks for the

Purpose of Purchasing or Carrying

Margin Stock), and X (Borrowers of

Securities Credit) to reduce regulatory

distinctions between broker-dealers,

banks, and other lenders and to

implement changes in the Board’s

margin authority contained in the

National Securities Markets

Improvement Act of 1996 (proposed

earlier for public comment; Docket Nos.

R–0905, R–0923, and R–0944); and (b)

publication for comment of an advance

notice of proposed rulemaking to amend

Regulations T, U, and X.

2. Any items carried forward from a

previously announced meeting.

Note: This meeting will be recorded for the

benefit of those unable to attend. Cassettes

will be available for listening in the Board’s

Freedom of Information Office, and copies

may be ordered for $6 per cassette by calling

202–452–3684 or by writing to: Freedom of

Information Office, Board of Governors of the

Federal Reserve System, Washington, DC

20551.

CONTACT PERSON FOR MORE INFORMATION:

Joseph R. Coyne, Assistant to the Board;

202–452–3204.

SUPPLEMENTARY INFORMATION: You may

call 202–452–3206 for a recorded

announcement of this meeting; or you

may contact the Board’s Web site at

http://www.bog.frb.fed.us for an

electronic announcement. (The Web site

also includes procedural and other

information about the open meeting.)

Dated: December 11, 1997.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 97–32729 Filed 12–11–97; 10:36

am]

BILLING CODE 6210–01–P

FEDERAL RESERVE SYSTEM

Sunshine Act Meeting

AGENCY HOLDING THE MEETING: Board of

Governors of the Federal Reserve

System.

TIME AND DATE: Approximately 11 a.m.,

Thursday, December 18, 1997, following

a recess at the conclusion of the open

meeting.

PLACE: Marriner S. Eccles Federal

Reserve Board Building, 20th and C

Streets NW., Washington, DC 20551.

STATUS: Closed.

MATTERS TO BE CONSIDERED:

1. Personnel actions (appointments,

promotions, assignments,

reassignments, and salary actions)

involving individual Federal Reserve

System employees.

2. Any matters carried forward from a

previously announced meeting.

CONTACT PERSON FOR MORE INFORMATION:

Joseph R. Coyne, Assistant to the Board;

202–452–3204.

SUPPLEMENTARY INFORMATION: You may

call 202–452–3206 beginning at

approximately 5 p.m. two business days

before the meeting for a recorded

announcement of bank and bank

holding company applications

scheduled for the meeting; or you may

contact the Board’s Web site at http://

www.bog.frb.fed.us for an electronic

announcement that not only lists

applications, but also indicates

procedural and other information about

the meeting.

Dated: December 11, 1997.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 97–32730 Filed 12–11–97; 10:36

am]

BILLING CODE 6210–01–P

FEDERAL TRADE COMMISSION

[Dkt. C–3726]

Baxter International Inc.; Prohibited

Trade Practices, and Affirmative

Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Consent Order.

SUMMARY: In settlement of alleged

violations of federal law prohibiting

unfair or deceptive acts or practices and

unfair methods of competition, this

consent order requires, among other

things, Baxter International (‘‘Baxter’’),

an Illinois-based corporation, to divest

its Autoplex product to a Commissionapproved buyer, and to license Immuno

International AG’s (‘‘Immuno’’) product

in development to a Commissionapproved licensee within four months

of the date Baxter signs the consent.

This would resolve antitrust concerns

raised by the $463 million acquisition of

Immuno by Baxter, which both

manufacture a wide variety of biologic

products derived from human blood

plasma.

DATES: Complaint and Order issued

March 24, 1997.1

FOR FURTHER INFORMATION CONTACT:

Pamela Taylor, FTC/S–2308,

Washington, D.C. 20580. (202) 326–

2237.

SUPPLEMENTARY INFORMATION: On Friday,

January 3, 1997, there was published in

the Federal Register, 62 FR 408, a

proposed consent agreement with

analysis In the Matter of Baxter

International Inc., for the purpose of

soliciting public comment. Interested

parties were given sixty (60) days in

which to submit comments, suggestions

or objections regarding the proposed

form of the order.

No comments having been received,

the Commission has ordered the

issuance of the complaint in the form

contemplated by the agreement, made

its jurisdictional findings and entered

an order to divest, as set forth in the

proposed consent agreement, in

disposition of this proceeding.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46, Interpret

or apply sec. 5, 38 Stat. 719, as amended; sec.

7, 38 Stat. 731, as amended; 15 U.S.C. 45, 18)

Benjamin I. Berman,

Acting Secretary.

[FR Doc. 97–32636 Filed 12–12–97; 8:45 am]

BILLING CODE 6750–01–M

FEDERAL TRADE COMMISSION

[Dkt. C–3725]

Ciba-Geigy Limited, et al.; Prohibited

Trade Practices, and Affirmative

Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Consent Order.

SUMMARY: In settlement of alleged

violations of federal law prohibiting

unfair or deceptive acts or practices and

unfair methods of competition, this

consent order requires, among other

things, the licensing of specified gene

therapy technology and patent rights to

Rhone-Poulene Rorer, Inc., to put

Rhone-Poulene in a position to compete

against the combined firm. The consent

order also requires divestiture of the

Sandoz U.S. and Canadian corn

herbicide assets to BASF and its flea

control business to Central Garden & Pet

Company or another Commissionapproved buyer.

DATES: Complaint and Order issued

March 24, 1997.1
Federal Register / Vol. 62, No. 240 / Monday, December 15, 1997 / Notices 65707

available from the Commission’s Public Reference

Branch, H–130, 600 Pennsylvania Avenue, N.W.,

Washington, D.C. 20580.

1Copies of the Complaint and the Decision and

Order are available from the Commission’s Public

Reference Branch, H–130, 600 Pennsylvania

Avenue, NW., Washington, DC 20580.

1Copies of the Complaint and the Decision and

Order are available from the Commission’s Public

Reference Branch, H–130, 600 Pennsylvania

Avenue, NW., Washington, DC 20580.

FOR FURTHER INFORMATION CONTACT:

Howard Morse or William Baer, FTC/H–

394, Washington, D.C. 20580. (202) 326–

2949 or 326–2932.

SUPPLEMENTARY INFORMATION: On Friday,

January 3, 1997, there was published in

the Federal Register, 62 FR 409, a

proposed consent agreement with

analysis In the Matter of Ciba-Geigy

Limited, et al., for the purpose of

soliciting public comment. Interested

parties were given sixty (60) days in

which to submit comments, suggestions

or objections regarding the proposed

form of the order.

No comments having been received,

the Commission has ordered the

issuance of the complaint in the form

contemplated by the agreement, made

its jurisdictional findings and entered

an order to divest, as set forth in the

proposed consent agreement,

indisposition of this proceeding.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret

or apply sec. 5, 38 Stat. 719, as amended; sec.

7, 38 Stat. 731, as amended; 15 .S.C. 45, 18)

Benjamin I. Berman,

Acting Secretary.

[FR Doc. 97–32635 Filed 12–12–97; 8:45 am]

BILLING CODE 6750–01–M

FEDERAL TRADE COMMISSION

[Dkt. C–3727]

Jeanette L. Douglas Co.; Prohibited

Trade Practices, and Affirmative

Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Consent Order.

SUMMARY: In settlement of alleged

violations of federal law prohibiting

unfair or deceptive acts or practices and

unfair methods of competition, this

consent order prohibits, among other

things, Jeanette L. Douglas, an officer of

Computer Business Services, Inc.

(‘‘CBSI’’), from misrepresenting the

earnings or success rate of CBSI

investors; the existence of a market for

CBSI’s products or services; the amount

of time it takes investors to recoup their

investments; and from making any

representation regarding the

performance, benefits, efficacy or

success rate of any product or service

unless she possesses reliable evidence

to substantiate the claims. The consent

order also prohibits the use of

misleading testimonials or

endorsements and requires certain

disclosures to investors.

DATES: Complaint and Order issued

March 24, 1997.1

FOR FURTHER INFORMATION CONTACT:

C. Steven Baker or Catherine Fuller,

Federal Trade Commission, Chicago

Regional Office, 55 East Monroe St.,

Suite 1860, Chicago, IL 60603. (312)

353–8156 or (312) 353–5576.

SUPPLEMENTARY INFORMATION: On Friday,

January 17, 1997, there was published

in the Federal Register, 62 FR 2671, a

proposed consent agreement with

analysis In the Matter of Jeanette L.

Douglas Co., for the purpose of

soliciting public comment. Interested

parties were given sixty (60) days in

which to submit comments, suggestions

or objections regarding the proposed

form of the order.

No comments having been received,

the Commission has ordered the

issuance of the complaint in the form

contemplated by the agreement, made

its jurisdictional findings and entered

an order to cease and desist, as set forth

in the proposed consent agreement, in

disposition of this proceeding.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interprets

or applies sec. 5, 38 Stat. 719, as amended;

15 U.S.C. 45)

Benjamin I. Berman,

Acting Secretary.

[FR Doc. 97–32637 Filed 12–12–97; 8:45 am]

BILLING CODE 6750–01–M

FEDERAL TRADE COMMISSION

[Dkt. C–3728]

Phillips Petroleum Company;

Prohibited Trade Practices, and

Affirmative Corrective Actions

AGENCY: Federal Trade Commission.

ACTION: Consent order.

SUMMARY: In settlement of alleged

violations of federal law prohibiting

unfair or deceptive acts or practices and

unfair methods of competition, this

consent order requires, among other

things, the Oklahoma-based corporation

to divest approximately 160 miles of

pipeline belonging to ANR Pipeline

Company and Phillips in the Anadarko

Basin area, and to maintain the assets in

their current condition and to provide

customers under the contract with ANR

with gathering services at existing terms

and conditions pending divestiture. The

consent order also requires Phillips, for

ten years, to notify the Commission

before acquiring during any 18-month

period more than five miles of gas

gathering pipelines in the specified

areas of the Oklahoma counties.

DATES: Complaint and Order issued

March 28, 1997.1

FOR FURTHER INFORMATION CONTACT:

George Cary, FTC/H–374, Washington,

DC 20580. (202) 326–3741.

SUPPLEMENTARY INFORMATION: On Friday,

January 10, 1997, there was published

in the Federal Register, 62 FR 1459, a

proposed consent agreement with

analysis In the Matter of Phillips

Petroleum Company, for the purpose of

soliciting public comment. Interested

parties were given sixty (60) days in

which to submit comments, suggestions

or objections regarding the proposed

form of the order.

No comments have been received, the

Commission has ordered the issuance of

the complaint in the form contemplated

by the agreement, made its

jurisdictional findings and entered an

order to divest, as set forth in the

proposed consent agreement, in

disposition of this proceeding.

(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret

or apply sec. 5, 38 Stat. 719, as amended; sec.

7, 38 Stat. 731, as amended; 15 U.S.C. 45, 18)

Benjamin I. Berman,

Acting Secretary.

[FR Doc. 97–32638 Filed 12–12–97; 8:45 am]

BILLING CODE 6750–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Agency for Toxic Substances and

Disease Registry; Senior Executive

Service; Performance Review Board

Members

AGENCY: Centers for Disease Control and

Prevention (CDC), and Agency for Toxic

Substances and Disease Registry

(ATSDR), Department of Health and

Human Services.

ACTION: Notice.

SUMMARY: Title 5, U.S. Code, Section

4314(c)(4) of the Civil Service Reform

Act of 1978, Pub. L. 95–454, requires

that appointment of Performance

Review Board members be published in

the Federal Register.

FOR FURTHER INFORMATION CONTACT:

Connie Clayton, Human Resources

Management Office, Office of Program

Support, Centers for Disease Control

and Prevention, 4770 Buford Highway,